Description
A multi-kinase inhibitor (IC50s = 0.3, 16, 1.5, 8.7, and 1.4 nM for EGFR, ErbB2, KDR, FLT4, and EphB4, respectively); selective for these kinases over a panel of 10 tyrosine kinases and 55 serine/threonine kinases at 10 μM; inhibits growth of A431 cells expressing wild-type EGFR and H1975 NSCLC cells expressing both EGFRL858R and EGFRT790M (IC50s = 13 and 920 nM, respectively); inhibits tumor growth and EGFR phosphorylation in an H1975 mouse xenograft model at 10, 30, and 100 mg/kg
Formal name: N-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-[[(3aα,5β,6aα)-octahydro-2-methylcyclopenta[c]pyrrol-5-yl]methoxy]-4-quinazolinamine
Synonyms: EXEL-7647|Tesevatinib
Molecular weight: 491.4
CAS: 781613-23-8
Purity: ≥98%
Formulation: A solid
Product Type|Biochemicals|Kinase Inhibitors|EGFR/ErbB/HER Family||Product Type|Biochemicals|Kinase Inhibitors|VEGFR Family||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer|Cell Signaling|Growth Factor Receptor Signaling||Research Area|Cancer|Multidrug Resistance